Outcomes after heart transplantation in sensitized patients bridged with ventricular assist devices.

Charles D Fraser Xun ZhouJ Trent MagruderAlejandro Suarez-PierreCecillia LuiJoshua C GrimmRobert HigginsAhmet Kilic

Published in: Journal of cardiac surgery (2019)

The use of ventricular assist devices did not impact survival or rejection within 1 year of HTx in highly sensitized patients. Highly sensitized recipients have similar outcomes regardless of prior LVAD support or type of LVAD used as a bridge to transplantation.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
heart failure
left ventricular
peritoneal dialysis
bone marrow
patient reported
skeletal muscle
weight loss
insulin resistance
left ventricular assist device
glycemic control